Pharmacologic weight management and GLP-1-based therapies: Pharmacologic weight management using GLP-1 receptor agonists and dual incretin agonists represents an emerging preventive strategy for knee osteoarthritis, particularly among individuals with obesity. Here, GLP1R is linked to Obesity.